Welcome to COMPPARE

A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer

Recent news

COMPPARE Enrolls 1,500th Proton Patient, Reaches…

Category: Homepage Feature

The COMPPARE Coordinating Center announced today that the study has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for…

COMPPARE has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for the proton cohort

COMPPARE Achieves 75% Enrollment Milestone

Category: Recent News

The COMPPARE Coordinating Center announced today that the study achieved 75% enrollment on May 3, 2022. COMPPARE realized both a remarkable…

COMPPARE Reaches Enrollment Milestone

From Principles to Practice: Building…

Category: Recent News

On November 17, Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, participated in a…

From Principles to Practice: Building Partnerships for Trust and Equity in Health Research with COMPPARE

For participants

Meet the Team

COMPPARE clinicians, researchers, patients, and other stakeholders

Who we are

For Healthcare providers

ClinicalTrials.gov

Privately and publicly funded clinical studies conducted around the world.

VTOC Login

Medical Team sign-in page

Contact the COMPPARE Team